| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr9_0073100 | Intergenic-Intergenic | chr9:113642276-113642540 | chr9:110879996-110880260 | 265 nt | 0.4302 |
| hsa_LPAR1_0001600 | Intron-Exon-Intron | chr9:113659775-113704448 | chr9:110897495-110942168 | 191 nt | 0.3979 |
| hsa_LPAR1_0001700 | Intron-Exon-Intron | chr9:113659775-113735838 | chr9:110897495-110973558 | 78 nt | 0.5000 |
| hsa_LPAR1_0001800 | Intron-Exon-Intron | chr9:113659775-113773970 | chr9:110897495-111011690 | 291 nt | 0.4364 |
| hsa_LPAR1_0001900 | Intron-Exon-Intron | chr9:113669559-113735838 | chr9:110907279-110973558 | 78 nt | 0.5000 |
| hsa_LPAR1_0002000 | Intron-Exon-Intron | chr9:113669573-113735838 | chr9:110907293-110973558 | 250 nt | 0.3720 |
| hsa_chr9_0073200 | Intergenic-Intergenic | chr9:113672350-113673599 | chr9:110910070-110911319 | 1250 nt | 0.3936 |
| hsa_chr9_0073300 | Intergenic-Intergenic | chr9:113677604-113679558 | chr9:110915324-110917278 | 1955 nt | 0.3683 |
| hsa_LPAR1_0002100 | Intron-Intron | chr9:113679716-113680076 | chr9:110917436-110917796 | 361 nt | 0.3934 |
| hsa_chr9_0073400 | Intergenic-Intergenic | chr9:113701515-113701873 | chr9:110939235-110939593 | 359 nt | 0.3872 |
A study in humans demonstrated that the circLPAR1 is expressed at low levels in muscle-invasive bladder cancer (MIBC) tissues, where its low expression predicts worse disease-specific survival and is associated with invasion and metastasis [Di Agostino et al. DOI:10.3389/fcell.2020.00389].